Prestige Consumer Healthcare (PBH) Fails to deliver data

Key failure to deliver metrics for Prestige Consumer Healthcare:

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: NZ$1.54 M
• Last 3 months FTD volume: NZ$4.32 M
• Last year FTD volume: NZ$4.32 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013

Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	NZ$57.35 M	NZ$99.79 M	🇬🇧 UK
Pfizer PFE	NZ$48.65 M	NZ$0.35 B	🇺🇸 USA
Rite Aid RAD	NZ$12.18 M	NZ$30.91 M	🇺🇸 USA
Johnson & Johnson JNJ	NZ$81.31 M	NZ$0.33 B	🇺🇸 USA
Taro Pharmaceutical TARO	N/A	NZ$0.82 M	🇮🇱 Israel
Novartis NVS	NZ$86.4 M	NZ$0.14 B	🇨🇭 Switzerland
Procter & Gamble PG	NZ$84.1 M	NZ$0.17 B	🇺🇸 USA
CVS Health CVS	NZ$22.69 M	NZ$0.17 B	🇺🇸 USA
Clorox CLX	NZ$24.06 M	NZ$39.51 M	🇺🇸 USA
Abbott Laboratories ABT	NZ$38.56 M	NZ$0.12 B	🇺🇸 USA